Concepts (56)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 6 | 2025 | 864 | 1.430 |
Why?
|
| Anticonvulsants | 5 | 2025 | 362 | 1.170 |
Why?
|
| Pyrrolidinones | 1 | 2025 | 22 | 0.910 |
Why?
|
| Electrocorticography | 1 | 2025 | 54 | 0.860 |
Why?
|
| Seizures | 6 | 2025 | 874 | 0.830 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2025 | 221 | 0.770 |
Why?
|
| Electroencephalography | 4 | 2025 | 848 | 0.710 |
Why?
|
| Sleep Deprivation | 1 | 2025 | 44 | 0.210 |
Why?
|
| Young Adult | 6 | 2025 | 9981 | 0.210 |
Why?
|
| Status Epilepticus | 2 | 2015 | 159 | 0.200 |
Why?
|
| Alprazolam | 1 | 2022 | 7 | 0.190 |
Why?
|
| Drug Resistant Epilepsy | 2 | 2015 | 273 | 0.180 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2023 | 92 | 0.180 |
Why?
|
| Adult | 8 | 2025 | 31012 | 0.150 |
Why?
|
| Aged | 5 | 2025 | 20820 | 0.150 |
Why?
|
| Middle Aged | 7 | 2025 | 28314 | 0.150 |
Why?
|
| Psychophysiologic Disorders | 1 | 2018 | 24 | 0.140 |
Why?
|
| Adolescent | 4 | 2025 | 20797 | 0.140 |
Why?
|
| Placebos | 1 | 2018 | 223 | 0.140 |
Why?
|
| Patient Readmission | 1 | 2021 | 436 | 0.130 |
Why?
|
| Prospective Studies | 2 | 2025 | 6401 | 0.120 |
Why?
|
| Treatment Outcome | 4 | 2025 | 12818 | 0.120 |
Why?
|
| Anesthetics, Dissociative | 1 | 2015 | 17 | 0.120 |
Why?
|
| Anesthetics, Intravenous | 1 | 2015 | 49 | 0.110 |
Why?
|
| Propofol | 1 | 2015 | 50 | 0.110 |
Why?
|
| Retrospective Studies | 6 | 2025 | 17537 | 0.110 |
Why?
|
| Acetamides | 1 | 2015 | 43 | 0.110 |
Why?
|
| Male | 7 | 2025 | 64378 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2021 | 901 | 0.100 |
Why?
|
| Female | 7 | 2025 | 70239 | 0.100 |
Why?
|
| Anxiety | 1 | 2019 | 1004 | 0.090 |
Why?
|
| Hospitalization | 1 | 2021 | 1935 | 0.090 |
Why?
|
| Ketamine | 1 | 2015 | 206 | 0.090 |
Why?
|
| Humans | 10 | 2025 | 130066 | 0.080 |
Why?
|
| Depression | 1 | 2019 | 1313 | 0.080 |
Why?
|
| Quality of Life | 1 | 2019 | 2072 | 0.080 |
Why?
|
| United States | 1 | 2025 | 11893 | 0.070 |
Why?
|
| Lasers | 1 | 2023 | 111 | 0.050 |
Why?
|
| Hospital Units | 1 | 2021 | 17 | 0.040 |
Why?
|
| Safety-net Providers | 1 | 2021 | 89 | 0.040 |
Why?
|
| Monitoring, Physiologic | 1 | 2021 | 371 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2022 | 1614 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 310 | 0.040 |
Why?
|
| Self Report | 1 | 2019 | 552 | 0.030 |
Why?
|
| Hypoxia, Brain | 1 | 2015 | 34 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 2015 | 137 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2015 | 172 | 0.030 |
Why?
|
| Comorbidity | 1 | 2019 | 1584 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2015 | 532 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 6765 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 1212 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 1166 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2015 | 525 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 3739 | 0.020 |
Why?
|
| Critical Care | 1 | 2015 | 686 | 0.020 |
Why?
|
| Child | 1 | 2015 | 26169 | 0.010 |
Why?
|